Arterial uptake of biodegradable nanoparticles: Effect of surface modifications

Journal of Pharmaceutical Sciences

Volumn 87, Issue 10, 1998, Pages 1229-1234

  Labhasetwar, Vinod ^a   Song, Cuxian ^b   Humphrey, Wllliam ^c   Shebuski, Ronald ^c   Levy, Robert J ^b,d  

^a UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c PFIZER INC   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIETHYLAMINOETHANOL; AMMONIUM DERIVATIVE; CYANOACRYLATE; DEXTRAN; DIDODECYLDIMETHYLAMMONIUM BROMIDE; DRUG CARRIER; EPOXIDE; FERRITIN; FIBRINOGEN; FIBRONECTIN; HEPARIN; LIPOFECTIN; NANOPARTICLE; PHOSPHATIDYLETHANOLAMINE; POLYGLACTIN; U 86983; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; CHEMICAL MODIFICATION; CORONARY ARTERY; DOG; DRUG ABSORPTION; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG RELEASE; DRUG UPTAKE; FEMORAL ARTERY; INTRAARTERIAL DRUG ADMINISTRATION; NONHUMAN; RESTENOSIS; SWINE; ZETA POTENTIAL;

EID: 0031709640     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js980021f     Document Type: Article

References (33)

1. Wilcox, J. N. Molecular Biology: Insight into the Causes and Prevention of Restenosis After Arterial Intervention. Am. J. Cardiol. 1993, 72, 88E-95E.
2. Koster, R.; Windstetter, U.; Uberfuhr, P.; Baumann, G.; Nikol, S.; Hofling, B. Enhanced Migratory Activity of Vascular Smooth Muscle Cells with High Expression of Platelet-derived Growth Factor A and B. Angiology 1995, 46, 99-106.
3. Hassenstein, S.; Hanke, H.; Kamenz, J.; Oberhoff, M.; Hanke, S.; Riessen, R.; Haase, K. K.; Betz, E.; Karsch, K. R. Vascular Injury and Time Course of Smooth Muscle Cell Proliferation after Experimental Holmium Laser Angioplasty. Circulation 1992, 86, 1575-1583.
4. Fuster, V.; Falk, E.; Fallon, J. T.; Badimon, L.; Chesebro, J. H.; Badimon, J. J. The Three Processes Leading to Post PTCA Restenosis: Dependence on the Lesion Substrate. Thromb. Haemost. 1995, 74, 552-559.
5. Popma, J. J.; Califf, R. M.; Topol, E. J. Clinical Trials of Restenosis after Coronary Angioplasty. Circulation 1991, 84, 1426-1436.
6. Lincoff, A. M.; Topol, E. J.; Ellis, S. G. Local Drug Delivery for the Prevention of Restenosis. Fact, Fancy, and Future. Circulation 1994, 90, 2070-2084.
7. Riessen, R.; Isner, J. M. Prospects for Site-specific Delivery of Pharmacologic and Molecular Therapies. J. Am. Coll. Cardiol. 1994, 23, 1234-1244.
8. Axel, D. I.; Kunert, W.; Goggelmann, C.; Oberhoff, M.; Herdeg, C.; Kuttner, A.; Wild, D. H.; Brehm, B. R.; Riessen, R.; Koveker, G.; Karsch, K. R.; Robinson, K. A.; Chronos, N. A.; Schieffer, E.; Palmer, S. J.; Cipolla, G. D.; Milner, P. G.; King, S. B.; Baumbach, A.; Oberhoff, M.; Bohnet, A.; Miljak, T.; Herdeg, C.; Horch, B.; Blessing, E.; Kunert, W.; Haase, K. K.; Karsch, K. R.; Pavlides, G. S.; Barath, P.; Maginas, A.; Vasilikos, V.; Cokkinos, D. V.; WW, O. N.; Oberhoff, M.; Herdeg, C.; Baumbach, A.; Shamet, K.; Kranzhofer, A.; Weingartner, O.; Rubsamen, K.; Kluge, M.; Karsch, K. R.; Hong, M. K; Wong, S. C.; Barry, J. J.; Bramwell, O.; Tjurmin, A.; Leon, M. B.; Schwarzacher, S. P.; Lim, T. T.; Wang, B.; Kernoff, R. S.; Niebauer, J.; Cooke, J. P.; Yeung, A. C.; Hodgkin, D. D.; Pierpont, G. L.; Hildebrand, K. R.; Gornick, C. C. Paclitaxel Inhibits Arterial Smooth Muscle Cell Proliferation and Migration In Vitro and In Vivo Using Local Drug Delivery. Circulation 1997, 96, 636-645.
9. Fram, D. B.; Aretz, T.; Azrin, M. A.; Mitchel, J. F.; Samady, H.; Gillam, L. D.; Sahatjian, R.; Waters, D.; McKay, R. G. Localized Intramural Drug Delivery During Balloon Angioplasty using Hydrogel-coated Balloons and Pressure-augmented Diffusion. J. Am. Coll. Cardiol. 1994, 23, 1570-1577.
10. Villa, A. E.; Guzman, L. A.; Chen, W.; Golomb, G.; Levy, R. J.; Topol, E. J. Local Delivery of Dexamethasone for Prevention of Neointimal Proliferation in a Rat Model of Balloon Angioplasty. J. Clin. Invest. 1994, 93, 1243-1249.
11. Edelman, E. R.; Adams, D. H.; Karnovsky, M. J. Effect of Controlled Adventitial Heparin Delivery on Smooth Muscle Cell Proliferation Following Endothelial Injury. Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 3773-3777.
12. Lambert, T. L.; Dev, V.; Rechavia, E.; Forrester, J. S.; Litvack, F.; Eigler, N. L. Localized Arterial Wall Drug Delivery From a Polymer-coated Removable Metallic Stent. Kinetics, Distribution, and Bioactivity of Forskolin. Circulation 1994, 90, 1003-1011.
13. Labhasetwar, V.; Chen, B.; Muller, D. W. M.; Bonadio, J.; Ciftci, K.; March, K.; Levy, R. J. Gene-based Therapies for Restenosis. Adv. Drug Del. Rev. 1997, 24, 109-120.
14. Labhasetwar, V.; Song, C.; Levy, R. J. Nanoparticle Drug Delivery for Restenosis. Adv. Drug Del. Rev. 1997, 24, 63-85.
15. Humphrey, W. R.; Erickson, L. A.; Simmons, C. A.; Northrup, J. L.; Wishka, D. G.; Morris, J.; Labhasetwar, V.; Song, C.; Levy, R. J.; Shebuski, R. J. The Effect of Intramural Delivery of Polymeric Nanoparticles Loaded With the Antiproliferative 2-Aminochromone U-86983 on Neointimal Hyperplasia Development in Balloon-injured Coronary Arteries. Adv. Drug Del. Rev. 1997, 24, 87-108.
16. Guzman, L.; Labhasetwar, V.; Song, C.; Jang, Y.; Lincoff, M. A.; Levy, R. J.; Topol, E. J. Local Intraluminal Infusion Of Biodegradable Polymeric Nanoparticles. A Novel Approach For Prolonged Drug Delivery after Balloon Angioplasty. Circulation 1996, 94, 1441-1448.
17. Song, C.; Labhasetwar, V.; Murphy, H.; Qu, X.; Humphrey, W. R.; Shebuski, R. J.; Levy, R. J. Formulation and Characterization of Biodegradable Nanoparticles for Intravascular Local Drug Delivery. J. Control. Relat. 1997, 43, 197-212.
18. Calis, S.; Jeyanthi, R.; Tsai, T.; Mehta, R. C.; DeLuka, P. P. Adsorption of Salmon Calcitonin to PLGA Microspheres. Pharm. Res. 1995, 12, 1072-1076.
19. Humphrey, W. R.; Simmons, C. A.; Toombs, C. F.; Shebuski, R. J. Induction of Neointimal Hyperplasia by Coronary Angioplasty Balloon Overinflation: Comparison of Feeder Pigs to Yucatan Minipigs. Am. Heart J. 1994, 127, 20-31.
20. Rupert, L. A. M.; Hoekstra, D.; Engberts, B. F. N. Fusogenic Behavior of Didodecyldimethylammonium Bromide Bilayer Vesicles. J. Am. Chem. Soc. 1985, 107, 2628-2631.
21. Wilensky, R. L.; March, K. L.; Hathaway, D. R. Direct Intraarterial Wall Injection of Microparticles Via a Catheter: A Potential Drug Delivery Strategy Following Angioplasty. Am. Heart J. 1991, 112, 1136-1140.
22. Wilensky, R. L.; March, K. L.; Gradus-Pizlo, I.; Spaedy, A. J.; Hathaway, D. R. Methods and Devices for Local Drug Delivery in Coronary and Peripheral Arteries. Trends Cardiovas. Med. 1993, 3, 163-170.
23. Rome, J. J.; Shayani, V.; Flugelman, M. Y.; Newman, K. D.; Farb, A.; Virmani, R.; Dichek, D. A. Anatomic Barriers Influence the Distribution of In Vivo Gene Transfer into the Arterial Wall. Modeling with Microscopic Tracer Particles and Verification with a Recombinant Adenoviral Vector. Arterioscler. Thromb. 1994, 14, 148-161.
24. Wolinsky, H. Local Delivery: Let's Keep Our Eyes on the Wall. J. Am. Coll. Cardiol. 1994, 24, 825-827.
25. Fernandez, O. A.; Meyer, B. J.; Mailhac, A.; Falk, E.; Badimon, L.; Fallon, J. T.; Fuster, V.; Chesebro, J. H.; Badimon, J. J. A New Approach for Local Intravascular Drug Delivery. Iontophoretic Balloon. Circulation 1994, 89, 1518-1522.
26. Hodgkin, D. D.; Pierpont, G. L.; Hildebrand, K. R.; Gornick, C. C. Electrophysiologic Characteristics of a Pulsed Iontophoretic Drug-Delivery System in Coronary Arteries. J. Cardiovasc. Pharmacol. 1997, 29, 39-44.
27. Gimple, L. W.; Gertz, D.; Haber, H. L.; Ragosta, D.; Powers, E. R.; Roberts, W. C.; Sarembock, I. J. Effect of Chronic Subcutaneous or Intramural Administration of Heparin on Femoral Artery Restenosis After Balloon Angioplasty in Hypercholesterolemic Rabbits: A Quantitative Angiographic and Histopathological Study. Circulation 1992, 86, 1536-1546.
28. Feigner, P. L. Particulate Systems and Polymers for In Vitro and In Vivo Delivery of Polynucleotides. Adv. Drug Del. Rev. 1990, 5, 163-187.
29. Zimmer, A.; Mustschler, E.; Lambrecht, G.; Mayer, D.; Kreuter, J. Pharmacokinetic and Pharmacodynamic Aspects of an Ophthalmic Pilocarpine Nanoparticle-Delivery-System. Pharm. Res. 1994, 11, 1435-1442.
30. Product Information, D., Nagase America Co., New York.
31. Fukui, R.; Shibata, N.; Kphbayashi, E.; Amakawa, M.; Furutama, D.; Hoshida, M.; Negoro, N.; Nakakouji, T.; Ii, M.; Ishihara, T.; Ohsawa, N. Inhibition Of Smooth Muscle Cell Migration by the P21 Cyclin-Dependent Kinase Inhibitor. Atherosclerosis 1997, 132, 53-59.
32. Henrikson, K. P.; Quirk, S. M.; Restivo, A. Expression of Rat Thrombin Receptor and Mutants in the Baculovirus-Infected Cell System. Thrombosis Res. 1997, 87, 205-214.
33. Lieske, J. C.; Norris, R.; Toback, F. G. Adhesion of Hydroxyapatite Crystals to Anionic Sites on the Surface of Renal Epithelial Cells. Am. J. Physiol. 1997, 273, F224-233.